FC gamma receptor IIB (FCGR2B) overexpression in hematopoietic progenitor cells triggers the generation and expansion of myeloid-derived suppressor cells (MDSC) that target cytotoxic CD8+ T cells, thus hampering the intrinsic anti-tumor immune response [28]. The gene discussed is FCGR2B; the disease is neoplasm.